{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:02:47Z","timestamp":1782298967534,"version":"3.54.5"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1093\/ecco-jcc\/jjx042","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T16:13:12Z","timestamp":1489680792000},"page":"970-974","source":"Crossref","is-referenced-by-count":15,"title":["Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Arie","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Yerushalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Broide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Mozer-Glassberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Shaoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija-Leena","family":"Kolho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Shteyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Shamaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Ledder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Peleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Sarbagili","family":"Shabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gili","family":"Focht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebby","family":"Shachmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Boaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"On","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"key\n\t\t\t\t20170728065404_CIT0001","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification","volume":"17","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170728065404_CIT0002","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management","volume":"6","year":"2012","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170728065404_CIT0003","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPG.0b013e3182662233","article-title":"Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines","volume":"55","author":"European Crohn\u2019s and Colitis Organization; European Society for Paediatric Gastroenterology, Hepatology, and Nutrition","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t20170728065404_CIT0004","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Practice Parameters Committee of the American College of Gastroenterology","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170728065404_CIT0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ibd.23013","article-title":"Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry","volume":"19","author":"EUROKIDS Porto IBD Working Group of ESPGHAN","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170728065404_CIT0006","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.2004.060103","article-title":"Combined oral and enema treatment with Pentasa [mesalazine] is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study","volume":"54","year":"2005","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170728065404_CIT0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MPG.0b013e31826ac41a","article-title":"Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis","volume":"56","author":"Pediatric Inflammatory Bowel Disease Collaborative Research Group","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t20170728065404_CIT0008","article-title":"Once versus twice daily mesalazine to induce remission in paediatric ulcerative colitis: A randomised controlled trial","year":"2016","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170728065404_CIT0009","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"European Society of Pediatric Gastroenterology, Hepatology, and Nutrition","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t20170728065404_CIT0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170728065404_CIT0011","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/ibd.20867","article-title":"Appraisal of the pediatric ulcerative colitis activity index [PUCAI]","volume":"15","author":"Pediatric IBD Collaborative Research Group","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170728065404_CIT0012","first-page":"CD004118","article-title":"Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"11","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170728065404_CIT0013","first-page":"674","article-title":"Topical treatment with 5-ASA and hydrocortisone","volume":"12","year":"1986","journal-title":"Riv Ital Pediatr"},{"key":"key\n\t\t\t\t20170728065404_CIT0014","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ibd.21256","article-title":"Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents","volume":"16","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170728065404_CIT0015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2000.01940.x","article-title":"A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis","volume":"95","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170728065404_CIT0016","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","article-title":"Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis","volume":"40","year":"1997","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170728065404_CIT0017","first-page":"CD004115","article-title":"Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"1","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170728065404_CIT0018","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2010.04354.x","article-title":"Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis","volume":"32","author":"BudMesa-Study Group","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20170728065404_CIT0019","first-page":"2830","article-title":"Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis","volume":"19","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key\n\t\t\t\t20170728065404_CIT0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00042737-199606000-00010","article-title":"Beclomethasone dipropionate [3 mg] versus 5-aminosalicylic acid [2 g] versus the combination of both [3 mg\/2 g] as retention enemas in active ulcerative proctitis","volume":"8","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170728065404_CIT0021","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.crohns.2013.08.007","article-title":"Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life","volume":"8","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170728065404_CIT0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.crohns.2009.08.003","article-title":"Mesalazine vanishing time from rectal mucosa following its topical administration","volume":"4","year":"2010","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170728065404_CIT0023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.crohns.2013.03.005","article-title":"Topical therapy is underused in patients with ulcerative colitis","volume":"8","author":"Swiss IBD Cohort Study Group","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170728065404_CIT0024","first-page":"e194","article-title":"Is topical therapy underused in patients with ulcerative colitis? Our experience","volume":"48","year":"2014","journal-title":"Dig Liver Dis"},{"key":"key\n\t\t\t\t20170728065404_CIT0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gutjnl-2014-307008","article-title":"Outcome measures for clinical trials in paediatric IBD: An evidence-based, expert-driven practical statement paper of the Paediatric ECCO Committee","volume":"64","year":"2015","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170728065404_CIT0026","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cgh.2013.04.049","article-title":"Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/11\/8\/970\/19356176\/jjx042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T14:57:01Z","timestamp":1658847421000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1093\/ecco-jcc\/jjx042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,3,23]]},"published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx042","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}